Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI Impairment Charges

Impairment Charges at other companies

ADMA Biologics logo
ADMA BiologicsADMA
$0—
Charles River Laboratories logo
Charles River LaboratoriesCRL
$15.86M+50.0%

Segments

By segment

See full
TriLink$605K-77.6%
Corporate$0-100%
Cygnus$0—

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Questions, answered.

What does impairment charges mean?
Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.